VJHemOnc is committed to improving our service to you

ASH 2019 | CAR-T as a frontline standard of care in ALL?

VJHemOnc is committed to improving our service to you

Stephan Grupp

Stephan Grupp, MD, PhD, Children’s Hospital of Philadelphia, Philadelphia, PA, discusses whether CAR-T therapy can be a frontline standard of care and first-line therapy in acute lymphoblastic leukemia (ALL). This interview took place at the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition in Orlando, FL.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter